# Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke

Study · id `cardio:ct-nct01949948` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01949948](<https://clinicaltrials.gov/study/NCT01949948>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01949948

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1050 participants.

## Technical summary

Registry record NCT01949948. Randomized; double masking; primary purpose treatment. Start 2012-09 (actual); primary completion 2016-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1050 participants (enrolled count; ClinicalTrials.gov record NCT01949948, source copy `cardio:ctgov-nct01949948-2017-05-09`, retrieved 2026-10-26)
- Started: 2012-09 (actual) (ClinicalTrials.gov record NCT01949948, source copy `cardio:ctgov-nct01949948-2017-05-09`, retrieved 2026-10-26)
- Primary completion: 2016-12-31 (actual) (ClinicalTrials.gov record NCT01949948, source copy `cardio:ctgov-nct01949948-2017-05-09`, retrieved 2026-10-26)
- Completion: 2016-12-31 (actual) (ClinicalTrials.gov record NCT01949948, source copy `cardio:ctgov-nct01949948-2017-05-09`, retrieved 2026-10-26)
- Countries: Norway (ClinicalTrials.gov record NCT01949948, source copy `cardio:ctgov-nct01949948-2017-05-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01949948-2017-05-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke
- Acronym: NOR-TEST
- Condition: Ischemic Stroke
- Intervention (Drug): Tenecteplase
- Intervention (Drug): Alteplase
- Lead sponsor: Lars Thomassen
- Lead sponsor class: OTHER
- Collaborator: The Research Council of Norway
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Tenecteplase (`cardio:tenecteplase`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial (`cardio:pubmed-28780236`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale (`cardio:pubmed-30602354`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke (`cardio:pubmed-31009339`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clinical outcomes and safety profile of Tenecteplase in wake-up stroke (`cardio:pubmed-32511749`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Tenecteplase versus alteplase after acute ischemic stroke at high age (`cardio:pubmed-32631157`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Sex differences in the Norwegian Tenecteplase Trial (NOR-TEST) (`cardio:pubmed-34564893`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Association between blood pressure and outcome in patients with acute ischemic stroke treated with alteplase (`cardio:pubmed-41360194`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f9d1dbfcd64b3e6ce09441fd9caf60e5edb87553d524c54d396f6e58d30cdb79
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
